WallStreetZenWallStreetZen

NASDAQ: CNTG
Centogene Nv Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their CNTG stock forecasts and price targets.

Forecast return on equity

Is CNTG forecast to generate an efficient return?

Forecast return on assets

Is CNTG forecast to generate an efficient return on assets?

CNTG revenue forecast

What is CNTG's revenue in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
$64.0M+14.93%

CNTG vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
CNTG$0.46N/AN/A
CHEK$2.26N/AN/A
STRR$0.85N/AN/A
TRIB$1.88N/AN/A
PMD$2.56N/AN/A

Centogene Nv Stock Forecast FAQ

What is CNTG's revenue growth forecast for 2024-2024?

(NASDAQ: CNTG) Centogene Nv's forecast annual revenue growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Centogene Nv's revenue in 2024 is $55,117,391.

In 2024, CNTG is forecast to generate $1,767,237,273 in revenue, with the lowest revenue forecast at $1,767,237,273 and the highest revenue forecast at $1,767,237,273.

If you're new to stock investing, here's how to buy Centogene Nv stock.

What is CNTG's forecast return on assets (ROA) for 2024-2024?

(NASDAQ: CNTG) forecast ROA is N/A, which is lower than the forecast US Diagnostics & Research industry average of 10.84%.

What is CNTG's forecast return on equity (ROE) for 2024-2024?

(NASDAQ: CNTG) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.